Clinical Trial Update: Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets [NA]

View source ↗

Summary

A pilot bioequivalence study of a chiglitazar/metformin extended-release tablet is planned, and the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Chiglitazar (Chiglitazar)
• metformin (metformin)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: T2DM (Type 2 Diabetes Mellitus) | NA | Status: NOT_YET_RECRUITING